GL1X · GenesisL1 explorer

Research workbench

Structure of the SARS-cov-2 main protease in complex with inhibitor MPI32

Analyse Structure of the SARS-cov-2 main protease in complex with inhibitor MPI32 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7S6Y
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
8GW
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30625% helix, 28% strandP0DTD1

Ligands and binding sites

  • 8GW · (1R,2S,5S)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-N-{(2S,3R)-4-[(cyclopropylmethyl)amino]-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11880.500.77298GW
21470.450.7625empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7S6Y · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI32 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.